Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Ticker SymbolMGRX
Company nameMangoceuticals Inc
IPO dateMar 21, 2023
CEOCohen (Jacob D)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 21
Address15110 Dallas Pkwy, Suite 600
CityDALLAS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75248
Phone18336264679
Websitehttps://www.mangorx.com/
Ticker SymbolMGRX
IPO dateMar 21, 2023
CEOCohen (Jacob D)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data